Find partners
The William Blair Thinking Podcast

The William Blair Thinking Podcast

Hosted by William Blair

BusinessInvestingInterviews guests

Episodes

79

Latest episode

Jun 2026

Language

EN-US

About the show

The William Blair Thinking Podcast aims to provide in-depth expertise on today's financial and economic landscape. William Blair Thinking Podcast features two series: -William Blair Thinking Presents, a new podcast series that dives deep into conversation with our award-winning equity research and capital advisory experts. -Biotech Breakthroughs, a new podcast series from our equity research group that explores the news and trends shaping the biotech industry. For more, go to https://www.williamblair.com/Thinking Copyright 2026 William Blair & Company. L.L.C. “William Blair” and R Docs are registered trademarks of William Blair & Company, L.L.C. As used on this podcast, William Blair refers to William Blair & Company LLC, William Blair Investment Management, LLC and affiliates. For more information about William Blair, go to www.williamblair.com. This content is for informational and educational purposes only and not intended as investment advice or recommendation to buy or sell any security. Investment advice and recommendations can be provided only after careful consideration of an investor’s objectives, guidelines and restrictions. The views and opinions expressed are those of the speakers, and are subject to change over time as market and other factors evolve.

Listen to episodes

60 recent
June 16, 2026Episode 8011 min

Race to Infinite Labor: The Humanoid Hypothesis

William Blair industrials analyst Ross Sparenblek discusses how humanoid robotics could mark a structural shift in productivity by extending AI’s capabilities from digital tasks into real-world physical labor. He outlines the key forces accelerating adoption, from demographic pressures to supply chain dynamics, while highlighting both the long-term opportunity and the technical and scaling challenges still ahead.

June 1, 2026Episode 7922 min

Monthly Macro: Resilient Equities, Rising Yields, and a Shifting Playbook

As geopolitical tensions persist and inflation concerns resurface, equity markets remain resilient while bond markets signal a more cautious outlook. Richard de Chazal unpacks what’s driving this divergence, the durability of the U.S. consumer, and why quality may be coming back into focus.

May 18, 202622 min

Shifting Sites of Care: Why Healthcare Delivery Is Moving Beyond the Hospital

Ryan Daniels, William Blair's group head of healthcare technology and services research , discusses how policy reform, reimbursement changes, technology innovation, and consumer preferences are accelerating a shift in care delivery toward outpatient, virtual, and home based settings. He outlines why this trend is reaching an inflection point in 2026 and what it could mean for providers, payers, employers, and healthcare investors.

May 11, 202627 min

From Code to Clinic: How AI Is (and Isn’t) Rewriting the Life of a Drug

AI is transforming drug discovery, but not by replacing the lab. In this episode of William Blair Thinking Presents, Matt Larew, partner and equity research analyst covering life science tools and diagnostics, explains where AI is accelerating early discovery, why wet lab validation still matters, and what real progress looks like as adoption moves from hype to practice.

May 6, 202627 min

Monthly Macro: Strait of Hormuz Shock Meets Sticky Inflation

War-driven energy shocks, sticky inflation, and an unusually split Fed are back at the center of the macro conversation. In this month’s Monthly Macro, William Blair macro analyst Richard de Chazal assesses what those dynamics, and the growing influence of AI, mean for bonds, equities, and portfolio risk.

April 20, 202638 min

Biotech Breakthroughs: Gene Editing Moves Beyond the Hype

In this episode of Biotech Breakthroughs, Matt Phipps, group head of biotech research, speaks with William Blair biotech analyst Myles Minter about how gene editing is moving from early hype toward clinically validated therapies. They discuss lessons from the first approved ex vivo product and highlight key 2026 catalysts across CRISPR, base editing, RNA editing, and DNA writing.

April 1, 202626 min

Monthly Macro: Geopolitical Shock, Inflation Risks, and a Market on Edge

William Blair macro analyst Richard de Chazal unpacks the market implications of the U.S.–Iran conflict, discussing how the war is reshaping inflation and growth risks and challenging central banks’ playbooks, and why markets may be underpricing the possibility of a more prolonged disruption. Richard also touches on emerging stress in private credit beneath the surface.

March 3, 202622 min

Monthly Macro: AI Anxiety, Software Selloffs, and the Search for Winners

William Blair macro analyst Richard de Chazal and co-head of technology, media, and communications research, Jason Ader, unpack the sharp selloff in software stocks and the growing fear around AI-driven disruption. They explore why the “software apocalypse” narrative may be overblown, how AI could ultimately expand the software market, and what investors should watch as winners and losers begin to separate.

February 5, 202628 min

Monthly Macro: Geopolitics, Inflation, and the Fed

William Blair macro analyst Richard de Chazal breaks down rising geopolitical tensions, sticky inflation risks, Fed policy uncertainty, and the durability of U.S. growth amid fiscal stimulus and the evolving AI-driven productivity cycle.

December 19, 202524 min

Monthly Macro: 2026 Economic Outlook

William Blair macro analyst Richard de Chazal discusses why 2026 looks brighter for the economy, exploring the impact of AI-driven investment, evolving policy risks, and the surprising strength of the American consumer. *This episode was recorded December 16th, 2025

Is this your show?

Claim this listing to keep it up to date, reach guests who want to pitch you, and manage bookings with Guestify.

Claim this listing

More Business podcasts